DSCAM-AS1 is implicated in multiple tumorigenic processes, from DNA replication to chromosome separation, and is highly expressed in breast cancer and is regulated by estrogen; furthermore, it associates with clinical aggressiveness in breast cancer and also associates with estrogen as well as tamoxifen-associated gene signatures [43]. The gene discussed is DSCAM-AS1; the disease is breast cancer.